FR3041882B1 - Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion - Google Patents

Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion Download PDF

Info

Publication number
FR3041882B1
FR3041882B1 FR1502083A FR1502083A FR3041882B1 FR 3041882 B1 FR3041882 B1 FR 3041882B1 FR 1502083 A FR1502083 A FR 1502083A FR 1502083 A FR1502083 A FR 1502083A FR 3041882 B1 FR3041882 B1 FR 3041882B1
Authority
FR
France
Prior art keywords
pharmaceutical preparation
ischenie
reperfusion
lesions
preventive treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1502083A
Other languages
English (en)
Other versions
FR3041882A1 (fr
Inventor
Fabrice Prunier
Delphine Prunier
Juan Manuel Chao De La Barca
Pascal Reynier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chu Dangers
Universite dAngers
Original Assignee
Chu Dangers
Universite dAngers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chu Dangers, Universite dAngers filed Critical Chu Dangers
Priority to FR1502083A priority Critical patent/FR3041882B1/fr
Publication of FR3041882A1 publication Critical patent/FR3041882A1/fr
Application granted granted Critical
Publication of FR3041882B1 publication Critical patent/FR3041882B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une préparation pharmaceutique comprenant un composé aux effets cytoprotecteurs de type kynurénine ou son sel, en mélange racémique ou non-racémique, pour le traitement des lésions d'ischémie reperfusion. L'invention concerne également une méthode thérapeutique utilisant cette préparation.
FR1502083A 2015-10-06 2015-10-06 Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion Expired - Fee Related FR3041882B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1502083A FR3041882B1 (fr) 2015-10-06 2015-10-06 Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1502083 2015-10-06
FR1502083A FR3041882B1 (fr) 2015-10-06 2015-10-06 Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion

Publications (2)

Publication Number Publication Date
FR3041882A1 FR3041882A1 (fr) 2017-04-07
FR3041882B1 true FR3041882B1 (fr) 2019-04-12

Family

ID=56137363

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1502083A Expired - Fee Related FR3041882B1 (fr) 2015-10-06 2015-10-06 Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion

Country Status (1)

Country Link
FR (1) FR3041882B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265442B1 (en) * 1990-09-13 2001-07-24 The General Hospital Corporation Treatment of neurological diseases by increasing brain concentrations of kynurenic acid
AU710527B2 (en) * 1995-02-23 1999-09-23 Novartis Nutrition Ag Amino acid compositions and use thereof in clinical nutrition
TWI386396B (zh) * 2008-06-20 2013-02-21 Standard Chem & Pharm Co Ltd 阿朴芬化合物與含羧基藥劑之醫藥可接受鹽類及其製備方法

Also Published As

Publication number Publication date
FR3041882A1 (fr) 2017-04-07

Similar Documents

Publication Publication Date Title
EA201990495A1 (ru) Биарильные соединения, применимые в качестве иммуномодуляторов
CO2021004436A2 (es) Derivados de anillo tricíclico condensado como inhibidores de la fosfatasa de homología a src 2
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
EA201890857A1 (ru) Соединения, применимые в качестве иммуномодуляторов
EA201691857A1 (ru) Соединения, применимые в качестве иммуномодуляторов
EA201990221A1 (ru) 1,3-дигидроксифенильные производные, применимые в качестве иммуномодуляторов
PH12017502079A1 (en) Treatment of beta-thalassemia using actrii ligand traps
MA53399B1 (fr) Pyrazoles substitués en tant qu`inhibiteurs de la kallicréine plasmatique humaine
EA201692079A1 (ru) Ингибиторы лизин-специфической деметилазы-1
CL2015002529A1 (es) Compuestos de tetrahidropirrolotiazina
MY197440A (en) Heteroamatic compounds as btk inhibitors
PH12017500453A1 (en) Spirocyclic inhibitors of cathepsin c
PH12019502363A1 (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds
EA201791096A1 (ru) 4-оксо-3,4-дигидро-1,2,3-бензотриазины в качестве модуляторов gpr139
MA43052B1 (fr) Inhibiteurs de la kallicréine plasmatique humaine
PH12021551280A1 (en) Heteroaromatic compounds as vanin inhibitors
MX2021006489A (es) Compuestos heteroaromaticos como inhibidores de vanina.
JOP20210034A1 (ar) مركبات عطرية غير متجانسة كمثبطات Vanin
MY176521A (en) Pyrrole-substituted indolone derivative, preparation method therefor, composition comprising the same and use thereof
EA201890460A1 (ru) Композиции и способы лечения и предотвращения нейродегенеративных расстройств
FR3041882B1 (fr) Preparation pharmaceutique pour le traitement preventif de lesions d'ischenie reperfusion
MX2021006490A (es) Compuestos heteroaromaticos como inhibidores de vanina.
NZ735249A (en) Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer’s disease
MX2019000542A (es) Derivados de pirazolilaminobenzimidazol como inhibidores de jak.
MA43158B1 (fr) Composés oxa-diazadispiro possédant une activité contre la douleur

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Search report ready

Effective date: 20170407

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

ST Notification of lapse

Effective date: 20210605